Revolution Medicines (RVMD) Earnings Date, Estimates & Call Transcripts → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free RVMD Stock Alerts $38.46 -1.57 (-3.92%) (As of 12:45 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 8) -$0.70 Beat By $0.05 Consensus EPS (May. 8) -$0.75 Read Call TranscriptListen to Call Get Revolution Medicines Earnings AlertsEnter your email address below to receive the latest news and earnings results for RVMD and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRVMD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RVMD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Revolution Medicines Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.77)($0.70)($0.73)Q2 20243($0.77)($0.73)($0.75)Q3 20243($0.79)($0.77)($0.78)Q4 20243($0.82)($0.80)($0.81)FY 202412($3.15)($3.00)($3.07)Q1 20252($0.85)($0.83)($0.84)Q2 20252($0.88)($0.85)($0.87)Q3 20252($0.91)($0.88)($0.90)Q4 20252($0.90)($0.90)($0.90)FY 20258($3.54)($3.46)($3.50)RVMD Earnings Date and InformationRevolution Medicines last announced its earnings results on May 8th, 2024. The reported ($0.70) EPS for the quarter, beating analysts' consensus estimates of ($0.75) by $0.05. Its revenue for the quarter was down 100.0% compared to the same quarter last year. Revolution Medicines has generated ($3.75) earnings per share over the last year (($3.75) diluted earnings per share). Earnings for Revolution Medicines are expected to decrease in the coming year, from ($3.12) to ($3.54) per share. Revolution Medicines has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Revolution Medicines Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024(Estimated)------- 5/8/2024Q1 2024($0.75)($0.70)+$0.05($0.70)$1.37 million- 2/26/2024Q4 2023($0.85)($1.14)($0.29)($1.14)$1.20 million$0.74 million 11/6/2023Q3 2023($1.01)($0.99)+$0.02($0.99)$0.75 million- 8/8/2023Q2 2023($0.82)($0.92)($0.10)($0.92)$1.56 million$3.82 million 5/8/2023Q1 2023($0.84)($0.72)+$0.12($0.72)$2.94 million$7.01 million 2/27/2023Q4 2022($0.84)($0.63)+$0.21($0.63)$6.75 million$15.33 million Get the Latest News and Ratings for RVMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Revolution Medicines and its competitors with MarketBeat's FREE daily newsletter. 11/7/2022Q3 2022($0.87)($0.87)-($0.87)$8.57 million$3.36 million 8/9/2022Q2 2022($0.87)($0.82)+$0.05($0.82)$8.75 million$9.12 million5/9/2022Q1 2022($0.82)($0.78)+$0.04($0.78)$10.00 million$7.58 million 2/28/2022Q4 2021($0.65)($0.71)($0.06)($0.71)$8.20 million$9.46 million 11/10/2021Q3 2021($0.62)($0.72)($0.10)($0.72)$9.65 million$1.10 million 8/11/2021Q2 2021($0.56)($0.60)($0.04)($0.60)$10.81 million$8.70 million 5/10/2021Q1 2021($0.52)($0.53)($0.01)($0.53)$10.10 million$10.13 million3/1/2021Q4 2020($0.38)($0.52)($0.14)($0.52)$15.09 million$8.75 million11/12/2020Q3 2020($0.39)($0.42)($0.03)($0.42)$13.87 million$12.66 million8/10/2020Q2 2020($0.36)($0.46)($0.10)($0.46)$13.20 million$10.03 million5/14/2020Q1($0.3330)($0.74)($0.4070)($0.74)$13.18 million$11.55 million Revolution Medicines Earnings - Frequently Asked Questions When is Revolution Medicines's earnings date? Revolution Medicines has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on RVMD's earnings history. Did Revolution Medicines beat their earnings estimates last quarter? In the previous quarter, Revolution Medicines (NASDAQ:RVMD) reported ($0.70) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.75) by $0.05. Learn more on analysts' earnings estimate vs. RVMD's actual earnings. How can I listen to Revolution Medicines's earnings conference call? The conference call for Revolution Medicines's latest earnings report can be listened to online. Listen to Conference Call How can I read Revolution Medicines's conference call transcript? The conference call transcript for Revolution Medicines's latest earnings report can be read online. Read Transcript How much revenue does Revolution Medicines generate each year? Revolution Medicines (NASDAQ:RVMD) has a recorded annual revenue of $11.58 million. How much profit does Revolution Medicines generate each year? Revolution Medicines (NASDAQ:RVMD) has a recorded net income of -$436.37 million. RVMD has generated -$3.75 earnings per share over the last four quarters. What is Revolution Medicines's EPS forecast for next year? Revolution Medicines's earnings are expected to decrease from ($3.12) per share to ($3.54) per share in the next year. More Earnings Resources from MarketBeat Related Companies: EXEL Earnings Results IBRX Earnings Results HALO Earnings Results PCVX Earnings Results CRSP Earnings Results KRYS Earnings Results IMVT Earnings Results MRTX Earnings Results SWTX Earnings Results IOVA Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-Turn This page (NASDAQ:RVMD) was last updated on 5/21/2024 by MarketBeat.com Staff From Our Partners4 Cryptos BETTER than BitcoinTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.